4.31
-0.185(-4.12%)
Currency In USD
| Previous Close | 4.5 |
| Open | 4.5 |
| Day High | 4.5 |
| Day Low | 4.22 |
| 52-Week High | 11.42 |
| 52-Week Low | 1.23 |
| Volume | 272,827 |
| Average Volume | 963,949 |
| Market Cap | 145.32M |
| PE | -1.03 |
| EPS | -4.19 |
| Moving Average 50 Days | 4.3 |
| Moving Average 200 Days | 2.69 |
| Change | -0.19 |
If you invested $1000 in Inotiv, Inc. (NOTV) 10 years ago, it would be worth $2,042.65 as of February 05, 2025 at a share price of $4.31. Whereas If you bought $1000 worth of Inotiv, Inc. (NOTV) shares 5 years ago, it would be worth $868.95 as of February 05, 2025 at a share price of $4.31.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025
GlobeNewswire Inc.
Jan 22, 2025 9:05 PM GMT
WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and resear
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
GlobeNewswire Inc.
Dec 30, 2024 9:05 PM GMT
WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million
GlobeNewswire Inc.
Dec 23, 2024 9:05 PM GMT
WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and